Share

University Hospital Bristol has presented groundbreaking results at the British Radiation Safety Society (BRSS) conference, showcasing the use of TrueInvivo’s® DOSEmapper™ technology in gamma knife radiosurgery. The innovative micro silica bead TLD system provided precise dose measurements, ensuring accurate delivery and improved patient safety in stereotactic radiosurgery.
This marks a significant advancement in dosimetry, highlighting the potential of DOSEmapper™ to enhance radiation safety and accuracy in complex treatments.
Related Posts
TRUEinvivo's DOSEmapper™ technology receives enthusiastic feedback from industry leaders at ESTRO37 conference.
Revolutionary DOSEmapper™ reader produces glow curve graph, offering rapid measurement compared to traditional TLD readers.
TRUEinvivo wins Business Innovation of the Year Award for DOSEmapper™ technology, revolutionizing radiotherapy safety.
TRUEinvivo showcases micro silica beads at ICDA-2, University of Surrey, fostering international connections and collaborations.

